Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adipose-derived Regenerative Cells Treatment for Congestive Heart Failure

NCT06705023 is registered in ClinicalTrials.gov with Ralf Rothoerl as lead sponsor.

NCT NCT06705023
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06705023 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adipose-derived Regenerative Cells Treatment for Congestive Heart Failure
Lead sponsor
Ralf Rothoerl
Phase
Phase 2
Overall status
Recruiting
Start date
November 18, 2024
Completion date
December 31, 2025
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, heart failure, lv dysfunction, myocardial injury